Barclays PLC Pfizer Inc Transaction History
Barclays PLC
- $353 Billion
- Q1 2025
A detailed history of Barclays PLC transactions in Pfizer Inc stock. As of the latest transaction made, Barclays PLC holds 14,918,142 shares of PFE stock, worth $350 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
14,918,142
Previous 16,880,409
11.62%
Holding current value
$350 Million
Previous $448 Million
15.59%
% of portfolio
0.11%
Previous 0.13%
Shares
31 transactions
Others Institutions Holding PFE
# of Institutions
3,367Shares Held
3.61BCall Options Held
102MPut Options Held
130M-
Vanguard Group Inc Valley Forge, PA523MShares$12.3 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$9.97 Billion0.27% of portfolio
-
State Street Corp Boston, MA297MShares$6.98 Billion0.32% of portfolio
-
Geode Capital Management, LLC Boston, MA126MShares$2.95 Billion0.26% of portfolio
-
Wellington Management Group LLP Boston, MA103MShares$2.43 Billion0.52% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $132B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...